<DOC>
	<DOCNO>NCT02012777</DOCNO>
	<brief_summary>Propanolol beta blocker find inhibit ability epinephrine upregulate sickle red cell adhesion laminin endothelial cell vitro . The purpose pilot study administer one dose propanolol child sickle cell disease measure pre post dose red cell adhesion . The hypothesis single dose propanolol decrease red cell adhesion laminin endothelial cell compare baseline .</brief_summary>
	<brief_title>Propanolol Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease</brief_title>
	<detailed_description>A similar pilot study already conduct adult try child gather preliminary data grant submission . No safety issue find adult pilot study . This study evaluate effect different dos propanolol . The risk study involve risk three ( 3 ) blood draws risk propanolol . In order minimize risk child sickle cell disease asthma exclude asthma contraindication use propanolol . In addition , patient hypertensive bradycardic .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>1. diagnosis HbSS HbSBeta0Thal 2. age 1017 year 3 . Weight 30kg great 4 . Hb 7mg/dL great 5. informed consent 1 . History vasoocclusive crisis past 6 week , history transfusion past 3 month . 2. pregnancy 3. history heart failure , myocardial infarction , asthma , bradyarrythmias , hypotension , thyroid disease , diabetes , renal insufficiency 4. concurrent medication : antihypertensive medication , diuretic , thyroid replacement medication , arrythmia medication , insulin , hypoglycaemic medication 5. history allergy sulfonamides 6. elevated BUN creatinine</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>sickle cell disease</keyword>
	<keyword>propanolol</keyword>
	<keyword>red blood cell adhesion</keyword>
</DOC>